Cargando…

Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance

Introduction: The fecal immunochemical test (FIT) has been established as a cost-effective test in colon cancer screening programmes. This test could also be helpful in symptomatic patients prior to colonoscopy, but data about diagnostic performance, and accurate cut-off values for these patients ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Mercedes, Hijos, Gonzalo, Sostres, Carlos, Lué, Alberto, Puente-Lanzarote, Juan Jose, Carrera-Lasfuentes, Patricia, Lanas, Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492376/ https://www.ncbi.nlm.nih.gov/pubmed/32984360 http://dx.doi.org/10.3389/fmed.2020.00410

Ejemplares similares

Fecal Hemoglobin Concentration, a Good Predictor of Risk of Advanced Colorectal Neoplasia in Symptomatic and Asymptomatic Patients
por: Navarro, Mercedes, et al.
Publicado: (2019)

The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
por: Lué, Alberto, et al.
Publicado: (2020)

A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021)

A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

Evidence-Based Selection on the Appropriate FIT Cut-Off Point in CRC Screening Programs in the COVID Pandemic
por: Aznar-Gimeno, Rocío, et al.
Publicado: (2021)

Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex
por: Vanaclocha-Espi, Mercedes, et al.
Publicado: (2021)

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy
por: Laredo, Viviana, et al.
Publicado: (2020)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
por: Plantener, Eva, et al.
Publicado: (2022)

Lower Abnormal Fecal Immunochemical Test Cut-Off Values Improve Detection of Colorectal Cancer in System-Level Screens
por: Berry, Emily, et al.
Publicado: (2019)

Impact of the COVID-19 pandemic in colorectal cancer diagnosis and presentation
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test
por: Ribbing Wilén, Hanna, et al.
Publicado: (2022)

A73 EFFECT OF FECAL IMMUNOCHEMICAL TEST CUT-OFF LEVELS ON ADENOMA DETECTION RATE: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Zarandi-Nowroozi, M, et al.
Publicado: (2023)

The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
por: Domper-Arnal, María José, et al.
Publicado: (2022)

A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomatic
por: de Klerk, Clasine M, et al.
Publicado: (2017)

Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-analysis
por: Yaghoobi, Mohammad, et al.
Publicado: (2022)

Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screening
por: Kortlever, Tim L., et al.
Publicado: (2021)

AINE y riesgo digestivo
por: Marcén, Beatriz, et al.
Publicado: (2016)

Diagnosis and Treatment of Helicobacter pylori Infection in Real Practice—New Role of Primary Care Services in Antibiotic Resistance Era
por: Alfaro, Enrique, et al.
Publicado: (2023)

The Optimal Cut-Off Level of The Fecal Immunochemical Test For Colorectal Cancer Screening in a Country with Limited Colonoscopy Resources: A Multi-Center Study from Thailand
por: Aniwan, Satimai, et al.
Publicado: (2017)

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer
por: Hernandez-Ainsa, Maria, et al.
Publicado: (2022)

Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis
por: Urushikubo, Jun, et al.
Publicado: (2018)

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
por: Sostres, Carlos, et al.
Publicado: (2013)

Optimal cut‐off value of fecal calprotectin for the evaluation of ulcerative colitis: An unsolved issue?
por: Jha, Ashish Kumar, et al.
Publicado: (2018)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
por: van Turenhout, Sietze T, et al.
Publicado: (2014)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity
por: Jung, Yoonsuk, et al.
Publicado: (2021)

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
por: Hol, L, et al.
Publicado: (2009)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019
por: Ariño Pérez, Inés, et al.
Publicado: (2022)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Assessment of disease activity by fecal immunochemical test in ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2016)

Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
por: Kim, Nam Hee, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Improving Adenoma Detection Rates: The Role of the Fecal Immunochemical Test
por: Nwankwo, Eugene C, et al.
Publicado: (2021)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
por: Nielson, Carrie M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k9rha6m8jj22uci6c0ohtmhlg4